Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Goldstein

Showing results (51-60 of 234) with videos related to

Pageof 24
Sort By:
Annals of the New York Academy of Sciences|February 24, 2001
A single cell analysis of apoptosis. Ordering the apoptotic phenotypeJ C Goldstein, R M Kluck, D R Green
Open Forum Infectious Diseases|April 13, 2022
Overcoming <i>Stenotrophomonas maltophilia</i> Resistance for a More Rational Therapeutic ApproachRavina Kullar, Eric Wenzler, Jose Alexander, et al.
Archives of Otolaryngology (Chicago, Ill. : 1960)|July 1, 1982
Alternate innervations of facial musculatureS M Parnes, N Strominger, S Silver, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2020
<i>In Vitro</i> Activity of Tedizolid Compared to Linezolid and Five Other Antimicrobial Agents against 332 Anaerobic Isolates, Including Bacteroides fragilis Group, <i>Prevotella</i>, <i>Porphyromonas</i>, and <i>Veillonella</i> SpeciesEllie J C Goldstein, C Vreni Merriam, Diane M Citron
Frontiers in Medicine|June 6, 2018
Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-AnalysisLynne V McFarland, Charlesnika T Evans, Ellie J C Goldstein
Expert Opinion on Investigational Drugs|February 13, 2019
Investigational drug therapies currently in early-stage clinical development for the treatment of clostridioides (clostridium) difficile infectionMai-Chi N Tran, Ravina Kullar, Ellie J C Goldstein
Expert Review of Anti-Infective Therapy|August 12, 2014
Clostridium difficile: improving the prevention paradigm in healthcare settingsAngela Vassallo, Mai-Chi N Tran, Ellie J C Goldstein
Antimicrobial Agents and Chemotherapy|November 20, 2013
Comparative in vitro activities of SMT19969, a new antimicrobial agent, against 162 strains from 35 less frequently recovered intestinal Clostridium species: implications for Clostridium difficile recurrenceEllie J C Goldstein, Diane M Citron, Kerin L Tyrrell
Journal of Experimental Pharmacology|October 29, 2020
Investigational Treatment Agents for Recurrent <i>Clostridioides difficile</i> Infection (rCDI)Ravina Kullar, Mai-Chi N Tran, Ellie J C Goldstein
Diagnostic Microbiology and Infectious Disease|June 29, 2014
Comparative in vitro activities of dalbavancin and seven comparator agents against 41 Staphylococcus species cultured from osteomyelitis infections and 18 VISA and hVISA strainsDiane M Citron, Kerin L Tyrrell, Ellie J C Goldstein
Pageof 24

Showing results (51-60 of 234) with videos related to

Sort By:
Pageof 24
Annals of the New York Academy of Sciences|February 24, 2001
A single cell analysis of apoptosis. Ordering the apoptotic phenotypeJ C Goldstein, R M Kluck, D R Green
Open Forum Infectious Diseases|April 13, 2022
Overcoming <i>Stenotrophomonas maltophilia</i> Resistance for a More Rational Therapeutic ApproachRavina Kullar, Eric Wenzler, Jose Alexander, et al.
Archives of Otolaryngology (Chicago, Ill. : 1960)|July 1, 1982
Alternate innervations of facial musculatureS M Parnes, N Strominger, S Silver, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2020
<i>In Vitro</i> Activity of Tedizolid Compared to Linezolid and Five Other Antimicrobial Agents against 332 Anaerobic Isolates, Including Bacteroides fragilis Group, <i>Prevotella</i>, <i>Porphyromonas</i>, and <i>Veillonella</i> SpeciesEllie J C Goldstein, C Vreni Merriam, Diane M Citron
Frontiers in Medicine|June 6, 2018
Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-AnalysisLynne V McFarland, Charlesnika T Evans, Ellie J C Goldstein
Expert Opinion on Investigational Drugs|February 13, 2019
Investigational drug therapies currently in early-stage clinical development for the treatment of clostridioides (clostridium) difficile infectionMai-Chi N Tran, Ravina Kullar, Ellie J C Goldstein
Expert Review of Anti-Infective Therapy|August 12, 2014
Clostridium difficile: improving the prevention paradigm in healthcare settingsAngela Vassallo, Mai-Chi N Tran, Ellie J C Goldstein
Antimicrobial Agents and Chemotherapy|November 20, 2013
Comparative in vitro activities of SMT19969, a new antimicrobial agent, against 162 strains from 35 less frequently recovered intestinal Clostridium species: implications for Clostridium difficile recurrenceEllie J C Goldstein, Diane M Citron, Kerin L Tyrrell
Journal of Experimental Pharmacology|October 29, 2020
Investigational Treatment Agents for Recurrent <i>Clostridioides difficile</i> Infection (rCDI)Ravina Kullar, Mai-Chi N Tran, Ellie J C Goldstein
Diagnostic Microbiology and Infectious Disease|June 29, 2014
Comparative in vitro activities of dalbavancin and seven comparator agents against 41 Staphylococcus species cultured from osteomyelitis infections and 18 VISA and hVISA strainsDiane M Citron, Kerin L Tyrrell, Ellie J C Goldstein
Pageof 24